'Special K' party drug to be trialled as treatment for alcoholics

By REUTERS
July 7, 2016 02:15

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

British scientists are recruiting volunteers to test whether ketamine, also known as the party drug "Special K", may be helpful in reducing relapse rates among people with severe alcoholism.

After pilot studies that showed ketamine combined with psychotherapy might make detoxing alcoholics less likely to relapse, the scientists are looking for 96 volunteers with severe alcohol disorder who have been "recently abstinent".

Ketamine is a licensed medical drug, widely used as an anaesthetic and to relieve pain. But it is also used as a recreational drug and can lead some people into drug abuse.

"Ketamine is a well-tolerated drug and can help alleviate the symptoms of depression, with a pilot study suggesting that it could cut alcohol relapse rates by more than half," Celia Morgan, who will lead the research at Exeter University, said.

"This trial will allow us to examine whether ketamine, combined with therapy, can indeed help people stay abstinent from alcohol." Half the participants will get a low-dose ketamine

Related Content

Breaking news
August 21, 2018
Russia accuses UK of trying to foist its Russia policies on the EU, U.S.

By REUTERS